Cell therapy
Our expertise
We provide end-to-end bioanalytical support for adoptive cell therapies, including:
Targeted NGS panels, tumor profiling and mutational burden measurement
Precise measurement of specific T- or B-cell responses
Cellular target analysis and T-cell activation
Predictive biomarker assays, RNA expression profiling, gene persistence & virus safety testing
Ligand-binding and immunoassay solutions for tracking drug activity and immune response
Gene expression, vector copy number (VCN), and replication-competent virus testing (RCL/RCR)
Expert solutions for complex drug development challenges
With 40+ advanced technology platforms, we deliver unmatched flexibility and scalability. Our GCLP-compliant operations ensure regulatory-ready data, while integrated project management and high-throughput capacity keep your timelines on track.
Purpose‑built testing to accelerate cell therapy from IND to post‑market.
We design, validate, and perform specialty assays that assess phenotype, function, expansion/persistence, cytokine response, and safety for cell therapy programs across all phases of development.
Why work with Eurofins BioPharma Services
-
Clinical‑grade operations in a consolidated, purpose‑built facility.
-
Our scientific team includes recognized experts in bioanalysis, molecular testing, and flow cytometry who help shape industry best practices and guide clients through complex development challenges.
-
Purpose‑built qPCR (e.g., ExPeCT anti‑CD19/FMC63) for CAR‑T kinetics.
-
End‑to‑end coverage: cytokines/CRS, infectious disease/molecular, and clinical safety laboratories.
-
Harmonized live‑cell logistics and PBMC solutions for global, multi‑center studies.
-
Integrated bioinformatics for submission‑ready outputs.
Ready to accelerate your cell therapy program?
